Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease.

The inflammatory bowel diseases (IBD; Crohn's disease, ulcerative colitis) are a collection of chronic idiopathic inflammatory disorders of the intestine and/or colon. Although the pathophysiology of IBD is not known with certainty, a growing body of experimental and clinical data suggests that chronic gut inflammation may result from a dysregulated immune response to normal bacterial antigens. This uncontrolled immune system activation results in the sustained overproduction of reactive metabolites of oxygen and nitrogen. It is thought that some of the intestinal and/or colonic injury and dysfunction observed in IBD is due to elaboration of these reactive species. This review summarizes the current state-of-knowledge of the role of reactive oxygen species and nitric oxide in the pathophysiology of IBD.

[1]  M. Grisham,et al.  Effects of neutrophil-derived oxidants on intestinal permeability, electrolyte transport, and epithelial cell viability , 1990, Inflammation.

[2]  C. Obinger,et al.  Reaction of myeloperoxidase compound I with chloride, bromide, iodide, and thiocyanate. , 1998, Biochemistry.

[3]  M. Miller,et al.  Amelioration of chronic ileitis by nitric oxide synthase inhibition. , 1993, The Journal of pharmacology and experimental therapeutics.

[4]  D. Granger,et al.  Regulation of Murine Intestinal Inflammation by Reactive Metabolites of Oxygen and Nitrogen , 2001, The Journal of experimental medicine.

[5]  S. Abramson,et al.  The role of nitric oxide in inflammation and immunity. , 1998, Arthritis and rheumatism.

[6]  G. Rogler,et al.  Subtractive screening reveals up‐regulation of NADPH oxidase expression in Crohn's disease intestinal macrophages , 2001, Clinical and experimental immunology.

[7]  P. Libby,et al.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.

[8]  M. Currie,et al.  The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey. , 1997, The Journal of pharmacology and experimental therapeutics.

[9]  M. Mollet,et al.  Phase II trial of copper zinc superoxide dismutase (CuZnSOD) in treatment of Crohn's disease. , 1989, Free radical biology & medicine.

[10]  J. Doroshow,et al.  Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[11]  K. Matsumoto,et al.  Oxygen-derived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis. , 1989, Digestion.

[12]  E. Chang,et al.  Effect of the thiol-oxidizing agent diamide on NH2Cl-induced rat colonic electrolyte secretion. , 1993, The American journal of physiology.

[13]  R. Cashon,et al.  Redox reactions of hemoglobin and myoglobin: biological and toxicological implications. , 2001, Antioxidants & redox signaling.

[14]  R. Schmid,et al.  Inhibition of nitric oxide synthesis by aminoguanidine increases intestinal damage in the acute phase of rat TNB‐colitis , 2001, European journal of clinical investigation.

[15]  H. Verspaget,et al.  Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease. , 1991, Gut.

[16]  John I. Gallin,et al.  Inflammation: Basic Principles and Clinical Correlates , 1992 .

[17]  P. Kubes,et al.  Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. , 1997, Gastroenterology.

[18]  Dean P. Jones,et al.  Exogenous glutathione protects intestinal epithelial cells from oxidative injury. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Schorah Antioxidants in children with inflammatory bowel disease. , 1998, American Journal of Clinical Nutrition.

[20]  J. Davis,et al.  Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis. , 1997, The Journal of pharmacology and experimental therapeutics.

[21]  H. Lander An essential role for free radicals and derived species in signal transduction , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  D. Harrison,et al.  Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[24]  M. Grisham,et al.  Preparation and characterization of chloramines. , 1986, Methods in enzymology.

[25]  S. Weiss,et al.  Proteolytic inactivation of alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases. , 1992, The Journal of biological chemistry.

[26]  N. Oshitani,et al.  Location of superoxide anion generation in human colonic mucosa obtained by biopsy. , 1993, Gut.

[27]  H. Nick,et al.  Induction and immunolocalization of manganese superoxide dismutase in acute acetic acid-induced colitis in the rat. , 1995, Gastroenterology.

[28]  S. Pizzo,et al.  Oxidative dissociation of human alpha 2-macroglobulin tetramers into dysfunctional dimers. , 1994, The Journal of biological chemistry.

[29]  M. Grisham,et al.  Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. , 1994, The Journal of pharmacology and experimental therapeutics.

[30]  J. Weidner,et al.  Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. , 1996, Gastroenterology.

[31]  Barry Halliwell,et al.  Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils , 1998, Nature.

[32]  C. Elson,et al.  Experimental models of inflammatory bowel disease. , 1995, Gastroenterology.

[33]  H. Goto,et al.  Role Of Nitric Oxide Synthase Inhibitor In Experimental Colitis Induced By 2,4,6‐Trinitrobenzene Sulphonic Acid In Rats , 2001, Clinical and experimental pharmacology & physiology.

[34]  C. Pasquier,et al.  Phase II trial of copper zinc superoxide dismutase (CuZn SOD) in the treatment of Crohn's disease. , 1991, Free radical research communications.

[35]  A. Keshavarzian,et al.  Reactive oxygen and nitrogen metabolites as mediators of secretory diarrhea. , 1995, Gastroenterology.

[36]  E. Chang,et al.  Ca-mediated stimulation of Cl secretion by reactive oxygen metabolites in human colonic T84 cells. , 1992, The Journal of clinical investigation.

[37]  D. Lefer,et al.  Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. , 1998, Free radical biology & medicine.

[38]  F. Powrie,et al.  T cells in inflammatory bowel disease: protective and pathogenic roles. , 1995, Immunity.

[39]  M. Grisham Oxidants and free radicals in inflammatory bowel disease , 1994, The Lancet.

[40]  W. Doe,et al.  5-Aminosalicylic acid prevents oxidant mediated damage of glyceraldehyde-3-phosphate dehydrogenase in colon epithelial cells , 1999, Gut.

[41]  C. Herfarth,et al.  Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease , 1998, Gut.

[42]  M. Russel,et al.  Nutritional Supplementation with N‐3 Fatty Acids and Antioxidants in Patients with Crohn's Disease in Remission: Effects on Antioxidant Status and Fatty Acid Profile , 2000, Inflammatory bowel diseases.

[43]  F. Powrie,et al.  Regulatory T cells and inflammatory bowel disease. , 1999, Immunology today.

[44]  T. Aw Molecular and cellular responses to oxidative stress and changes in oxidation-reduction imbalance in the intestine. , 1999, The American journal of clinical nutrition.

[45]  D. Wink,et al.  I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[46]  R. Macdermott,et al.  Oxidant defense mechanisms in the human colon , 1990, Inflammation.

[47]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[48]  A. Keshavarzian,et al.  Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. , 1992, Gastroenterology.

[49]  O. Nielsen,et al.  Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. , 1990, Gastroenterology.

[50]  D. Roos,et al.  Interactions between the components of the human NADPH oxidase: a review about the intrigues in the phox family. , 1996, Frontiers in bioscience : a journal and virtual library.

[51]  M. Grisham Effect of 5-aminosalicylic acid on ferrous sulfate-mediated damage to deoxyribose. , 1990, Biochemical pharmacology.

[52]  Richard Graham Knowles,et al.  Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine. , 2001, The Journal of pharmacology and experimental therapeutics.

[53]  F. Powrie,et al.  CD4(+) regulatory T cells. , 2001, Current opinion in immunology.

[54]  J. Davis,et al.  Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: toxins, mediators, and modulators of gene expression. , 1996, Inflammatory bowel diseases.

[55]  S. Weiss Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[56]  P. Bass,et al.  Differences in the reducing power along the rat GI tract: Lower antioxidant capacity of the colon , 1999, Molecular and Cellular Biochemistry.

[57]  F. Powrie,et al.  Control of intestinal inflammation by regulatory T cells , 2001, Immunological reviews.

[58]  D. Learn,et al.  Mutagenic activity of chloramines. , 1987, Mutation research.

[59]  M. Yüksel,et al.  The effect of antioxidant therapy on colonic inflammation in the rat , 1999, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[60]  M. Grisham,et al.  Effects of nitric oxide synthase inhibition or sulfasalazine on the spontaneous colitis observed in HLA-B27 transgenic rats. , 1998, The Journal of pharmacology and experimental therapeutics.

[61]  J. Jackson,et al.  Mechanisms of hypochlorite injury of target cells. , 1990, The Journal of clinical investigation.

[62]  M. Grisham,et al.  Effects of aminosalicylates and immunosuppressive agents on nitric oxide-dependent N-nitrosation reactions. , 1994, Biochemical pharmacology.

[63]  S. Weitzman,et al.  Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. , 1990, Blood.

[64]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[65]  D. Rampton,et al.  Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. , 1992, Gastroenterology.

[66]  M. Baker,et al.  Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. , 1996, The Journal of clinical investigation.

[67]  L. Dubé,et al.  A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group For Ulcerative Colitis. , 1997, Gastroenterology.

[68]  S. Hazen,et al.  Eosinophil Peroxidase Oxidation of Thiocyanate , 2001, The Journal of Biological Chemistry.

[69]  C. Fiocchi Inflammatory bowel disease: etiology and pathogenesis. , 1998, Gastroenterology.

[70]  N. Nieto,et al.  Experimental Ulcerative Colitis Impairs Antioxidant Defense System in Rat Intestine , 2000, Digestive Diseases and Sciences.

[71]  P. Reilly,et al.  Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenon? , 1992, Pharmacology & therapeutics.

[72]  D. Learn,et al.  Myeloperoxidase-catalyzed chlorination of histamine by stimulated neutrophils , 2000, Redox report : communications in free radical research.

[73]  M. Neurath,et al.  Local administration of antisense phosphorothiate olignucleotides to the p65 subunit of NF–κB abrogates established experimental colitis in mice , 1996, Nature Medicine.

[74]  Y. Zhou,et al.  Role of copper zinc superoxide dismutase in the short-term treatment of acetic acid-induced colitis in rats. , 1996, Acta gastroenterologica Latinoamericana.

[75]  M. John,et al.  Enhanced Expression of iNOS in Inflamed Colons of IL‐2‐Deficient Mice Does Not Impair Colonic Epithelial Barrier Function , 2000, Annals of the New York Academy of Sciences.

[76]  A. Keshavarzian,et al.  Glutathione Content of Colonic Mucosa (Evidence for Oxidative Damage in Active Ulcerative Colitis) , 1998, Digestive Diseases and Sciences.

[77]  P. Libby,et al.  Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB (*) , 1995, The Journal of Biological Chemistry.

[78]  W. Doe,et al.  Depleted mucosal antioxidant defences in inflammatory bowel disease. , 1995, Free radical biology & medicine.

[79]  R. Haggitt,et al.  Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591. , 1997, Gastroenterology.

[80]  S. Hazen,et al.  Eosinophil peroxidase catalyzes bromination of free nucleosides and double-stranded DNA. , 2001, Biochemistry.

[81]  M. Grisham,et al.  Antioxidant properties of aminosalicylates. , 1994, Methods in enzymology.

[82]  Tamaki Yamada,et al.  The effects of sulfasalazine metabolites on hemoglobin-catalyzed lipid peroxidation. , 1991, Free radical biology & medicine.

[83]  P. Cerutti,et al.  The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B. , 1995, Chemistry & biology.

[84]  G. Garcı́a-Cardeña,et al.  Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. , 1997, The Journal of clinical investigation.

[85]  T. Aw,et al.  Biliary glutathione promotes the mucosal metabolism of luminal peroxidized lipids by rat small intestine in vivo. , 1994, The Journal of clinical investigation.

[86]  J. Stamler,et al.  Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. , 1995, Gut.

[87]  D. Rachmilewitz,et al.  Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. , 1995, Gut.

[88]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[89]  M. Grisham,et al.  Effect of nitric oxide on hemoprotein-catalyzed oxidative reactions. , 1998, Nitric oxide : biology and chemistry.

[90]  C. Hogaboam,et al.  The selective beneficial effects of nitric oxide inhibition in experimental colitis. , 1995, The American journal of physiology.

[91]  A. Blackburn,et al.  Protein carbonyl formation on mucosal proteins in vitro and in dextran sulfate-induced colitis. , 1999, Free radical biology & medicine.

[92]  S. Kawachi,et al.  Role of inducible nitric oxide synthase in the regulation of VCAM-1 expression in gut inflammation. , 1999, American journal of physiology. Gastrointestinal and liver physiology.